AMEDISYS INC's ticker is AMED and the CUSIP is 023436108. A total of 323 filers reported holding AMEDISYS INC in Q4 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $217,353 | -9.8% | 2,377 | -4.8% | 0.02% | +122.2% |
| Q3 2022 | $241,000 | -11.4% | 2,498 | -3.6% | 0.01% | -76.3% |
| Q2 2022 | $272,000 | -29.5% | 2,590 | +15.6% | 0.04% | -7.3% |
| Q1 2022 | $386,000 | -2.5% | 2,241 | -8.4% | 0.04% | 0.0% |
| Q4 2021 | $396,000 | -15.6% | 2,446 | -11.7% | 0.04% | -30.5% |
| Q3 2021 | $469,000 | +3.8% | 2,769 | +50.2% | 0.06% | -6.3% |
| Q2 2021 | $452,000 | -7.6% | 1,844 | -0.2% | 0.06% | -25.0% |
| Q1 2021 | $489,000 | +32.2% | 1,848 | +46.4% | 0.08% | +10.5% |
| Q4 2020 | $370,000 | +3.1% | 1,262 | -16.9% | 0.08% | -10.6% |
| Q3 2020 | $359,000 | +10.1% | 1,518 | -7.7% | 0.08% | 0.0% |
| Q2 2020 | $326,000 | +5.8% | 1,644 | -2.3% | 0.08% | -19.0% |
| Q1 2020 | $308,000 | -20.0% | 1,682 | -27.2% | 0.10% | +4.0% |
| Q4 2019 | $385,000 | +83.3% | 2,311 | +44.3% | 0.10% | +68.3% |
| Q3 2019 | $210,000 | – | 1,601 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RIVERBRIDGE PARTNERS LLC | 1,693,656 | $291,800,000 | 3.30% |
| Kent Lake Capital LLC | 30,000 | $5,169,000 | 3.21% |
| Lipe & Dalton | 22,802 | $3,929,000 | 1.92% |
| RK Capital | 54,900 | $9,459,000 | 1.86% |
| Millrace Asset Group, Inc. | 14,651 | $2,524,000 | 1.83% |
| Integral Health Asset Management, LLC | 40,000 | $6,892,000 | 1.79% |
| Bridge City Capital, LLC | 19,175 | $3,304,000 | 1.54% |
| Sivik Global Healthcare LLC | 20,000 | $3,446,000 | 1.42% |
| Bell Asset Management Ltd | 47,207 | $8,133,000 | 1.40% |
| Advantage Alpha Capital Partners LP | 53,680 | $9,249,000 | 1.38% |